摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-溴-3-氯苯丙酮 | 31736-73-9

中文名称
4'-溴-3-氯苯丙酮
中文别名
3-氯-4'-溴苯丙酮;4’-溴-3-氯苯丙酮;4-溴-3-氯苯丙酮
英文名称
4-bromophenyl 2-chloroethyl ketone
英文别名
1-(4-bromophenyl)-3-chloropropan-1-one;4'-bromo-3-chloropropiophenone
4'-溴-3-氯苯丙酮化学式
CAS
31736-73-9
化学式
C9H8BrClO
mdl
——
分子量
247.519
InChiKey
SYWQQEVHZPPLNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    54-59 °C(lit.)
  • 沸点:
    333.8±27.0 °C(Predicted)
  • 密度:
    1.5182 (rough estimate)
  • 闪点:
    >230 °F
  • LogP:
    3.2 at 22℃
  • 稳定性/保质期:
    如果遵照规格使用和储存则不会分解,未有已知危险反应。避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 危险品运输编号:
    NONH for all modes of transport
  • 海关编码:
    2914700090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    请将贮藏器密封并存放在阴凉、干燥处,同时确保工作环境有良好的通风或排气设施。

SDS

SDS:e24b61759459ed99d08e1f026eaf58e1
查看
Name: 4 -Bromo-3-Chloropropiophenone 99% Material Safety Data Sheet
Synonym: None known
CAS: 31736-73-9
Section 1 - Chemical Product MSDS Name:4 -Bromo-3-Chloropropiophenone 99% Material Safety Data Sheet
Synonym:None known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
31736-73-9 4'-Bromo-3-Chloropropiophenone 99 250-784-5
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 31736-73-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: brown
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H8BrClO
Molecular Weight: 247.52

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 31736-73-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4'-Bromo-3-Chloropropiophenone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 31736-73-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 31736-73-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 31736-73-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4'-溴-3-氯苯丙酮硫酸 作用下, 生成 5-溴茚酮
    参考文献:
    名称:
    Preparation, physical properties and n-type FET characteristics of substituted diindenopyrazinediones and bis(dicyanomethylene) derivatives
    摘要:
    一系列卤素和烷基取代的二茚并吡嗪二酮以及双(氰乙烯基)衍生物作为新型n型有机半导体,基于含氮杂环化合物进行了合成。引入卤素基团以改善电子注入。讨论了它们的晶体结构和固体物理性质。引入烷基基团以增加在有机溶剂中的溶解度。此外,通过对烷基基团的氧化引入了己酰基团,以增加溶解度和电子亲和力。还引入了双氰乙烯基团,以进一步增强电子接受特性。喷雾铸造和蒸气沉积的薄膜表现出n型场效应晶体管特性。
    DOI:
    10.1039/c2jm14955a
  • 作为产物:
    描述:
    1-(4-溴苯基)环丙醇1,10-菲罗啉次氯酸叔丁酯silver trifluoromethanesulfonate 作用下, 以 乙腈 为溶剂, 反应 6.0h, 以53%的产率得到4'-溴-3-氯苯丙酮
    参考文献:
    名称:
    银催化环烷醇的开环氯化反应选择性合成含羰基的烷基氯化物
    摘要:
    据报道,通过银催化的环烷醇的开环氯化反应,对含羰基的烷基氯化物有一种新颖的区域选择性方法。C(sp 3)–C(sp 3)键的裂解和C(sp 3)–Cl键的形成同时发生,在温和的条件下,收率很高,而且氯化产物易于转化为其他有用的合成中间体和药物。该反应具有完全的区域选择性,高效率和优异的实用性。
    DOI:
    10.1021/acs.orglett.5b03649
点击查看最新优质反应信息

文献信息

  • PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME
    申请人:Mikoshiba Katsuhiko
    公开号:US20120277423A1
    公开(公告)日:2012-11-01
    The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3: wherein R 1 is a substituted or unsubstituted aryl or heterocyclyl group, R 2 , R 3 , and R 4 are hydrogen atoms, n is 2, X is halogen, R 5 and R 6 independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R 5 and R 6 are not hydrogen atoms at the same time, or R 5 and R 6 may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.
    本发明涉及:一种具有转谷氨酰胺酶抑制活性的酮化合物,由下式1、2或3表示: 其中R1是取代或未取代的芳基或杂环基团,R2、R3和R4是氢原子,n是2,X是卤素,R5和R6独立地表示氢原子或取代或未取代的C1-C10烷基、芳基或芳烷基团,其中R5和R6不同时为氢原子,或者R5和R6可以共同形成含氮原子(N)的饱和或未饱和的、取代或未取代的杂环基团;包含该化合物的蛋白质交联抑制剂;以及包含该化合物或蛋白质交联抑制剂的用于预防或治疗由蛋白质交联引起的疾病的组合物。
  • A convenient enantioselective CBS-reduction of arylketones in flow-microreactor systems
    作者:Sonia De Angelis、Maddalena De Renzo、Claudia Carlucci、Leonardo Degennaro、Renzo Luisi
    DOI:10.1039/c6ob00336b
    日期:——

    A convenient, versatile, and green CBS-asymmetric reduction of aryl and heteroaryl ketones has been developed by using the microreactor technology.

    一种便捷、多用途且环保的CBS不对称还原芳基和杂芳基酮的方法已经通过使用微反应器技术得以开发。
  • NPY antagonists: spiroisoquinolinone derivatives
    申请人:Bristol-Myers Squibb Company
    公开号:US06348472B1
    公开(公告)日:2002-02-19
    A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of spiroisoquinolinone derivatives of Formula I. As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    一系列非肽类NPY拮抗剂已经合成,由式I的螺环异喹啉酮衍生物组成。 作为NPY诱导的进食行为的拮抗剂,预计这些化合物和已知类似物将作为有效的厌食剂,在促进减重和治疗进食障碍方面发挥作用。
  • Efficient AcrH <sub>2</sub> Catalyzed β‐Trifluoromethylation of Carbonyl Compounds by Atom Transfer Radical Addition Reactions
    作者:Zi‐Peng Rao、Yu‐Yang Sun、Xin‐Feng Zhou、Qiang Xie、Hui‐Xia Zhu、Jian‐Jun Dai、Jun Xu、Hua‐Jian Xu
    DOI:10.1002/cjoc.201900221
    日期:2019.10
    The use of organic catalysis AcrH2 enables the direct β‐trifluoromethylation of carbonyl compounds by atom transfer radical addition reactions with broad substrate scopes under mild conditions. This operationally simple and robust protocol successfully converts a variety of β‐chloro carbonyl compounds into the corresponding α‐chloro‐β‐fluoroalkylcarbonyl products. A significant advantage of this method
    有机催化AcrH 2的使用可在温和条件下通过广泛的底物范围内的原子转移自由基加成反应使羰基化合物直接进行β-三氟甲基化反应。该操作简单且功能强大的方案成功地将各种β-氯代羰基化合物转化为相应的α-氯代-β-氟代烷基羰基产品。该方法的显着优点是不需要使用金属催化剂,从而避免了药物合成中的金属残留问题。
  • Z-Selective ring opening of vinyl oxetanes with dialkyl dithiophosphate nucleophiles
    作者:B. Guo、J. T. Njardarson
    DOI:10.1039/c3cc46660d
    日期:——
    Dialkyl dithiophosphates selectively ring open vinyl oxetanes in excellent yields under mild reaction conditions to form useful allylic thiophosphate products with high Z-selectivity.
    在温和的反应条件下,二烷基二硫代磷酸盐能选择性地开环烯基环氧乙烷,以优异的产率生成具有高度Z-选择性的有用的烯丙基硫代磷酸酯产物。
查看更多